Security readout for executives and security teams
Plain-English summary
BioTime versions 8.5.4 and earlier are reported to allow a remote, low-privileged user to obtain sensitive information through an authorization weakness. The main business risk is confidentiality loss, not service disruption. Source data is limited and does not name a vendor patch.
Executive priority
Treat as a moderate confidentiality risk. Prioritize exposed or broadly accessible BioTime instances, then confirm vendor remediation because the source bundle does not provide a named patch.
Technical view
CVE-2023-51141 is mapped to CWE-639 and scored CVSS 6.5: network reachable, low complexity, low privileges required, no user interaction, high confidentiality impact, no integrity or availability impact. The CVE record names the Authentication & Authorization component but provides limited affected-product metadata.
Likely exposure
Organizations using ZKTeko BioTime v8.5.4 or earlier may be exposed, especially if the application is reachable from untrusted networks. The structured affected-product fields are incomplete and list vendor/product as n/a.
Exploitation context
The bundle does not show CISA KEV listing or other evidence of active exploitation. CVSS indicates exploitation requires some authenticated access, so risk increases where many users have accounts or access controls are weak.
Researcher notes
Evidence is sparse: the CVE names BioTime v8.5.4 and before, CWE-639, and the Authentication & Authorization component, but lacks CPEs, detailed affected builds, and remediation data. Avoid assuming exploit maturity from the public gist alone.
Mitigation direction
- Identify all BioTime deployments and confirm exact versions.
- Check vendor guidance for fixed versions or official mitigations.
- Restrict BioTime access to trusted networks or VPN users.
- Review user roles and remove unnecessary low-privilege accounts.
- Monitor for unusual authenticated access to sensitive records.
Validation and detection
- Confirm whether any instance runs BioTime v8.5.4 or earlier.
- Verify the application is not exposed directly to the internet.
- Review access-control tests for cross-user or cross-tenant data access.
- Check logs for unusual authenticated data reads.
- Document compensating controls if no vendor fix is available.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-639: Exact CWE lookup
Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2023-51141 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Medium
- CVSS
- 6.5 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
SSVC decision data
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N2.83.6CISA-ADPVulnerability scoring details
Base CVSS 3.1 score
6.5MediumVector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
Vulnerability timeline
Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.
- CVE reservedCVE Program
The CVE ID was reserved by the assigning CNA.
- CVE publishedCVE Program
The CVE record was published.
- CVE updatedCVE Program
The CVE record metadata indicates this as the latest update time.
ADP provider summaries
Source materials
- CVE List V5 sourceCVE List V5
- https://gist.github.com/ipxsec/1680d29c49fe368be81b037168175b10CVE reference, mitre
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Authorization Bypass Through User-Controlled Key
Authorization Bypass Through User-Controlled Key represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.